Certain tetracyclic compounds are described, which may be used in pharmaceuticalcompositions and methods for treating disease states, disorders, and conditionsmediated by fatty acid amide hydrolase (FAAH) activity. Thus, the compoundsmay be administered to treat, e.g., anxiety, pain, inflammation, sleep disorders,eating disorders, or movement disorders (such as multiple sclerosis).